Hydrazine hydrate (1:1) → (S)-2-((4-((S)-4-isopropyl-2-oxooxazolidin-3-yl)pyrimidin-2-yl)amino)propanehydrazide
반응식
[CH:1]([C@H:4]1[CH2:8][O:7][C:6](=[O:9])[N:5]1[C:10]1[CH:15]=[CH:14][N:13]=[C:12]([NH:16][C@@H:17]([CH3:22])[C:18](OC)=[O:19])[N:11]=1)([CH3:3])[CH3:2].O.[NH2:24][NH2:25]>>[CH:1]([C@H:4]1[CH2:8][O:7][C:6](=[O:9])[N:5]1[C:10]1[CH:15]=[CH:14][N:13]=[C:12]([NH:16][C@@H:17]([CH3:22])[C:18]([NH:24][NH2:25])=[O:19])[N:11]=1)([CH3:3])[CH3:2]참가 물질
3
실험 절차
To a solution of (S)-methyl 2-((4-((S)-4-isopropyl-2-oxooxazolidin-3-yl)pyrimidin-2-yl)amino)propanoate (120 mg, 0.39 mmol in 5 ml of MeOH) was added 99% hydrazine hydrate, the reaction solution was stirred at room temperature overnight (24 hours), the solvent was removed to yield the desired product (99 mg) in 78% yield, and was used for next step without purification. LCMS m/z 309.1 (M+H)+ RT=1.25 min.
후처리
- customthe solvent was removed
출처 및 근거
- ORD 기록
- ord-eb2bab16b08f4560b543cb4d78d8a189
- 출처 데이터셋
- uspto-grants-2015_02
- 특허 번호
- US08957068B2
반응 노트
불러오는 중…